4.4 Tuberculosis & Chronic/Unusual Pediatric Infections
Key Takeaways
- Pediatric TB is typically paucibacillary and primary-progressive, with hilar/mediastinal lymphadenopathy more typical than the cavitary adult pattern, and a known TB contact is often the most important diagnostic clue.
- Because children rarely produce sputum, early-morning gastric aspirates are a standard sampling method, and diagnosis frequently relies on a clinical/scoring approach combining exposure, symptoms, TST/IGRA, and imaging rather than waiting for culture confirmation.
- BCG vaccination is most protective against severe disseminated TB (miliary disease, TB meningitis) in early childhood, offers only modest and waning protection against pulmonary TB, and does not rule out active disease in an exposed, symptomatic child.
- Prior BCG vaccination can cause a false-positive TST, which is a key reason IGRA testing is preferred where available, especially years after vaccination.
- Brucellosis, visceral leishmaniasis, typhoid fever, and schistosomiasis belong on the regional fever-of-unknown-origin and hepatosplenomegaly differential alongside TB.
Pediatric Tuberculosis: Why Children Are Different
Tuberculosis (TB), caused by Mycobacterium tuberculosis, behaves differently in children than in adults, and the contrast is a recurring exam theme. Children -- especially those under 5 years -- are more likely to progress rapidly from infection to active disease, more likely to develop severe disseminated forms (miliary TB, TB meningitis), and are much harder to diagnose because their disease is typically paucibacillary (low organism burden) and they usually cannot produce sputum.
Children vs. Adults: Key Contrasts
| Feature | Adult TB | Pediatric TB |
|---|---|---|
| Typical disease type | Reactivation, cavitary, upper-lobe disease | Primary progressive disease; hilar/mediastinal lymphadenopathy is common |
| Bacillary burden | Often smear-positive | Usually paucibacillary -- sputum smear/culture frequently negative even with active disease |
| Sample collection | Expectorated sputum | Children often cannot expectorate; early-morning gastric aspirates, induced sputum, or nasopharyngeal aspirates are used |
| Extrapulmonary/disseminated risk | Lower | Higher, especially in infants -- miliary TB and TB meningitis are feared complications |
| Diagnosis | Often confirmed by microbiology | Frequently a clinical/scoring diagnosis combining exposure history, tuberculin skin test (TST) or interferon-gamma release assay (IGRA), chest imaging, and clinical findings, because microbiologic confirmation is harder to obtain |
The Primary Complex and Clinical Presentation
Most childhood TB is primary disease, meaning it develops soon after the child's first exposure rather than after years of latency. The classic radiologic finding is the Ghon complex (a peripheral parenchymal lesion, the Ghon focus, plus ipsilateral hilar/mediastinal lymphadenopathy); prominent hilar or mediastinal lymphadenopathy, sometimes causing airway compression with wheeze or collapse, is a more typical pediatric chest x-ray finding than the cavitary upper-lobe disease seen in adults. Presentation is often subtle and nonspecific: chronic (more than 2-3 weeks) cough, failure to thrive or weight loss, low-grade fever, night sweats, and a history of known TB contact (often a household adult) -- that contact history is frequently the single most important clue in an exam vignette, since children rarely have classic 'adult' TB symptoms.
Diagnostic Challenges
Because young children swallow rather than expectorate their respiratory secretions, sputum for acid-fast bacilli (AFB) smear and culture is difficult to obtain directly; early-morning gastric aspirates (collected before the child rises and re-swallows overnight secretions) are the traditional sampling method, though induced sputum and, where available, nasopharyngeal aspirates are increasingly used. Because culture yield and smear positivity are both low in children, diagnosis frequently relies on a clinical scoring/algorithmic approach that weighs: (1) history of contact with an infectious TB case, (2) suggestive symptoms, (3) a positive TST or IGRA, and (4) suggestive chest imaging -- rather than waiting for microbiologic confirmation, which can take weeks and may never be positive even in true disease.
Tuberculin skin testing (TST, the Mantoux test) and interferon-gamma release assays (IGRAs) both detect immune sensitization to M. tuberculosis antigens rather than active disease, and neither reliably distinguishes latent infection from active disease. An important exam-relevant nuance: prior BCG vaccination can cause a false-positive TST (because BCG shares antigens with M. tuberculosis), which is a major reason IGRAs -- whose antigens are not shared with the BCG vaccine strain -- are preferred where available and affordable, particularly in BCG-vaccinated populations.
BCG Vaccination
The Bacille Calmette-Guerin (BCG) vaccine, a live attenuated vaccine typically given at or shortly after birth in many countries where TB is endemic (including much of the Arab League region), is most protective in early childhood. It is roughly 70-80% effective against the most severe disseminated forms of childhood TB -- miliary TB and TB meningitis -- but its protection against pulmonary TB is more modest and wanes over time, and it provides little to no protection in adolescents and adults. Two exam-relevant consequences follow: (1) BCG vaccination does not rule out active TB in a symptomatic, exposed child, and (2) a documented BCG scar/history should not be used to dismiss a positive TST as purely vaccine-related once several years have passed since vaccination, because the cross-reactivity fades -- clinical and epidemiologic context (known contact, symptoms, imaging) should guide the decision, not the TST/BCG history alone.
Treatment Principles
Standard first-line treatment for drug-susceptible pulmonary TB in children follows the same multi-drug, multi-phase logic as in adults: an intensive phase (commonly isoniazid, rifampin, pyrazinamide, +/- ethambutol) followed by a continuation phase (isoniazid and rifampin), with total duration typically 6 months for uncomplicated pulmonary disease and longer courses for TB meningitis or disseminated/miliary disease. Children with confirmed latent TB infection (positive TST/IGRA, no active disease, normal chest x-ray, asymptomatic) are treated to prevent progression, most commonly with isoniazid monotherapy for several months (regimens and durations vary by national guideline), since children -- particularly infants -- carry a disproportionately high risk of progressing from latent infection to active, severe disease if untreated.
Contact Investigation and Preventive Therapy
When active pulmonary TB is diagnosed in a household member, contact investigation of exposed children is mandatory. An asymptomatic child with a positive TST or IGRA and no active disease on chest imaging is treated for latent TB infection to prevent progression to active disease -- commonly with isoniazid for several months (exact duration varies by national guideline), or alternative short-course regimens where available. A positive TST in a BCG-vaccinated child with known TB contact should be managed as infection, not dismissed as vaccine-related cross-reactivity.
Other Regionally Relevant Chronic/Unusual Infections
General pediatrics knowledge for the region also includes several endemic infections beyond TB:
- Brucellosis -- from unpasteurized dairy products or contact with infected livestock; presents with undulant (relapsing) fever, arthralgia, hepatosplenomegaly, and can mimic TB or lymphoma; treated with combination antimicrobials (age-adjusted regimens) because monotherapy relapses frequently.
- Visceral leishmaniasis (kala-azar) -- sandfly-transmitted; presents with prolonged fever, marked hepatosplenomegaly, pancytopenia, and weight loss.
- Typhoid fever (Salmonella typhi) -- prolonged (stepwise) fever, relative bradycardia, abdominal symptoms, and possible rose spots; a classic cause of prolonged fever of unknown origin (FUO) in returning travelers or endemic areas.
- Schistosomiasis -- freshwater exposure; hematuria (S. haematobium) or hepatosplenic/intestinal disease (S. mansoni), relevant to Nile-basin and other regional freshwater exposure histories.
These entities are worth recognizing as part of a broad fever of unknown origin (FUO) and hepatosplenomegaly differential alongside TB, particularly when a vignette includes travel, rural residence, or unpasteurized dairy/animal exposure history.
A 3-year-old with a documented household contact who has active pulmonary TB presents with 3 weeks of cough and weight loss. Chest x-ray shows hilar lymphadenopathy. Three induced sputum samples are AFB smear-negative. What is the most appropriate next step?
Which statement about BCG vaccination is most accurate?
A 6-year-old presents with several weeks of relapsing fever, arthralgia, and hepatosplenomegaly. The family recently returned from a rural area where they consumed unpasteurized goat milk. Which diagnosis is most consistent with this history?
Why are early-morning gastric aspirates commonly used to diagnose pulmonary TB in young children?